Olmis A 10/20mg Tablet

Olmis A 10/20mg Tablet is a medication that combines two active ingredients: Olmesartan & Amlodipine. Olmesartan is classified as an angiotensin II receptor blocker (ARB), while Amlodipine is a calcium channel blocker (CCB). This combination tablet is prescribed for the treatment of hypertension (high blood pressure), working synergistically to relax blood vessels and improve blood flow, thereby reducing blood pressure.

Uses:

Olmis A 10mg/20mg Tablet is indicated for the management of hypertension in adults. It is particularly beneficial for individuals whose blood pressure is inadequately controlled by monotherapy or for those who require initial dual therapy. Olmesartan blocks the action of angiotensin II, a hormone that constricts blood vessels, while Amlodipine relaxes blood vessels by inhibiting calcium influx into vascular smooth muscle cells. Together, they help lower blood pressure and decrease the risk of cardiovascular complications.

Side Effects:

Common side effects associated with Olmis A 10mg/20mg Tablet may include dizziness, headache, flushing, peripheral edema (swelling of the ankles or feet), fatigue, and gastrointestinal disturbances such as nausea or abdominal discomfort. Some individuals may experience more serious side effects like hypotension (low blood pressure), allergic reactions, or liver abnormalities. It is essential to report any adverse reactions to a healthcare provider promptly.

Precautions:

Before initiating Olmis A 10mg/20mg Tablet, patients should disclose their complete medical history and current medication regimen to their healthcare provider. This medication may interact with other drugs, so caution should be exercised when co-administering with other medications. Patients should avoid activities requiring mental alertness, such as driving or operating machinery, until they know how this medication affects them. Regular monitoring of blood pressure and kidney function may be necessary during treatment.

When Not to Use:

Olmis A 10mg/20mg Tablet is contraindicated in individuals with a known hypersensitivity to Olmesartan, Amlodipine, or any other components of the medication. It should not be used during pregnancy or breastfeeding, as it may pose risks to the fetus or infant. Patients with severe hepatic impairment or biliary obstruction should also avoid this medication. Caution is advised in patients with a history of angioedema related to previous ACE inhibitor or ARB therapy.